Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
tpmx
on March 19, 2021
|
parent
|
context
|
favorite
| on:
In a Phase III trial, Proxalutamide reduced mortal...
The company behind the drug tripled their market cap between November 2020 and March 2021. It's now at 11B HKD: Kintor Pharmaceutical (9939 HK).
Consider applying for YC's Winter 2026 batch! Applications are open till Nov 10
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
